Abbott Medical Devices

This study is checking how safe the Aveir leadless pacemaker is for people who need a heart pacemaker. About 304 people will take part, and researchers will watch for any serious problems related to the device or the implant procedure over three years. The goal is to make sure th…

This study is testing a device that replaces both a faulty heart valve and a damaged section of the main artery (aorta) in one surgery. About 260 people worldwide will receive the Abbott Valved Graft. Researchers will track how many patients survive and whether they need another …

This study is testing whether a new catheter and mapping system can safely and effectively treat Chinese patients with paroxysmal atrial fibrillation (a type of irregular heartbeat). About 200 participants will receive a catheter ablation procedure and be followed for 12 months. …

This early study tests a new tool called the Agilis RF Transseptal System, which uses radiofrequency energy to safely cross the wall between the upper chambers of the heart. The goal is to help doctors access the left side of the heart during treatments for heart rhythm issues or…

This study is testing a device called AMJ-401 in 50 people with ischemic heart disease in Japan. The goal is to see how well the device works by checking for strut fractures right after the procedure and how much the struts are covered by tissue after 6 months. Participants must …

This study is testing a new device called the Volt PFA System, which uses balloon-based energy to treat atrial fibrillation (AF), a common heart rhythm problem. Researchers will enroll 300 people with paroxysmal or persistent AF to see how safe and effective the procedure is in r…

This study looks at how safe and effective the Navitor heart valve is for people with severe aortic stenosis in everyday medical practice. About 100 participants will get the valve and be followed for 30 days. The main goals are to see how many survive and whether the valve leaks…

This study is tracking 2000 people who get an Abbott neurostimulator implant to manage chronic pain. Researchers will monitor safety and how well the device works over time in everyday life. The goal is to understand real-world benefits and risks, not to cure the pain.

This study is testing a new device called the Cephea Mitral Valve System to treat people with mitral valve disease (leaky or narrowed heart valves) who are not good candidates for open-heart surgery. The device is placed using a thin tube through a blood vessel, avoiding major su…

This study tests a brain pacemaker (deep brain stimulation) for adults with severe depression that hasn't improved with multiple treatments. The device targets a specific brain area to help regulate mood. Researchers will measure changes in depression scores and overall improveme…

This study tests whether a mechanical heart pump (HeartMate 3) can help people with advanced heart failure live longer and avoid serious complications like stroke or the need for a heart transplant. About 850 participants will either receive the pump or continue standard medical …

This study tests whether a small sensor implanted in the lung artery can help doctors better manage heart failure and reduce hospital visits. About 1000 adults with a history of heart failure will be followed to compare outcomes between those who get the sensor and those who do n…

This study follows 1000 people with movement disorders like Parkinson's disease, essential tremor, and dystonia who receive an Abbott deep brain stimulation (DBS) system. Researchers will measure changes in movement symptoms and track any serious side effects for up to 5 years. T…

This study is testing a new way to pace the heart called left bundle branch area pacing (LBBAP) in 200 people with conditions like slow heartbeat, heart failure, or atrial fibrillation. The goal is to see if this method is safe and works better than standard pacing over 6 months.…

This study looks at how well the TriClip system works and how safe it is for people in Japan with a leaky heart valve (tricuspid regurgitation). The device is already approved for use, and this study will follow 250 patients to confirm it controls the leak and has few complicatio…

This study tests a new device called the Cephea Mitral Valve System for people with a leaky or narrowed heart valve (mitral valve disease). The goal is to see if it is safe and works well for patients who are not good candidates for open-heart surgery. About 50 participants will …

This study is testing a medical device that uses gentle sound waves to break up hard calcium deposits inside heart arteries. The goal is to safely open severely hardened arteries so a stent can be placed more effectively. The study will enroll about 335 adults in the US with seve…

This study is a registry that collects information from 1,000 people with symptomatic mitral valve disease (leaky or narrowed heart valve). The goal is to learn how patients respond to a less-invasive valve replacement procedure called TMVR. This data will help doctors improve tr…

This study tests a new version of a heart imaging catheter (ViewFlex X ICE) that helps doctors see inside the heart during procedures for abnormal heart rhythms. About 500 adults who are already scheduled for a heart procedure will use this tool. The goal is to see if doctors can…

This study is a large registry that will follow 2500 people who receive Abbott heart devices (like those for hole-in-heart repairs or valve disease) during routine care. The goal is to confirm the devices are safe and work well in everyday hospital practice. Participants just rec…